chr3-190388285-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006580.4(CLDN16):​c.-45G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.219 in 1,613,798 control chromosomes in the GnomAD database, including 41,134 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 3026 hom., cov: 32)
Exomes 𝑓: 0.22 ( 38108 hom. )

Consequence

CLDN16
NM_006580.4 5_prime_UTR

Scores

1
1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.0520

Publications

14 publications found
Variant links:
Genes affected
CLDN16 (HGNC:2037): (claudin 16) Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. These junctions are comprised of sets of continuous networking strands in the outwardly facing cytoplasmic leaflet, with complementary grooves in the inwardly facing extracytoplasmic leaflet. The protein encoded by this gene, a member of the claudin family, is an integral membrane protein and a component of tight junction strands. It is found primarily in the kidneys, specifically in the thick ascending limb of Henle, where it acts as either an intercellular pore or ion concentration sensor to regulate the paracellular resorption of magnesium ions. Defects in this gene are a cause of primary hypomagnesemia, which is characterized by massive renal magnesium wasting with hypomagnesemia and hypercalciuria, resulting in nephrocalcinosis and renal failure. This gene and the CLDN1 gene are clustered on chromosome 3q28. [provided by RefSeq, Jun 2010]
CLDN16 Gene-Disease associations (from GenCC):
  • renal hypomagnesemia 3
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0047626793).
BP6
Variant 3-190388285-G-C is Benign according to our data. Variant chr3-190388285-G-C is described in ClinVar as Benign. ClinVar VariationId is 344445.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.24 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLDN16NM_006580.4 linkc.-45G>C 5_prime_UTR_variant Exon 1 of 5 ENST00000264734.3 NP_006571.2 Q9Y5I7
CLDN16NM_001378492.1 linkc.-45G>C 5_prime_UTR_variant Exon 5 of 9 NP_001365421.1
CLDN16NM_001378493.1 linkc.-45G>C 5_prime_UTR_variant Exon 4 of 8 NP_001365422.1
CLDN16XM_047447333.1 linkc.-45G>C 5_prime_UTR_variant Exon 3 of 7 XP_047303289.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLDN16ENST00000264734.3 linkc.-45G>C 5_prime_UTR_variant Exon 1 of 5 1 NM_006580.4 ENSP00000264734.3 Q9Y5I7
CLDN16ENST00000456423.2 linkc.-45G>C 5_prime_UTR_variant Exon 1 of 2 1 ENSP00000414136.2 F6SGM4
ENSG00000297357ENST00000747317.1 linkn.266C>G non_coding_transcript_exon_variant Exon 1 of 2
CLDN16ENST00000468220.1 linkn.306+13682G>C intron_variant Intron 3 of 4 4

Frequencies

GnomAD3 genomes
AF:
0.186
AC:
28239
AN:
151932
Hom.:
3027
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0905
Gnomad AMI
AF:
0.183
Gnomad AMR
AF:
0.175
Gnomad ASJ
AF:
0.269
Gnomad EAS
AF:
0.0263
Gnomad SAS
AF:
0.167
Gnomad FIN
AF:
0.257
Gnomad MID
AF:
0.291
Gnomad NFE
AF:
0.244
Gnomad OTH
AF:
0.212
GnomAD2 exomes
AF:
0.193
AC:
48454
AN:
250974
AF XY:
0.200
show subpopulations
Gnomad AFR exome
AF:
0.0857
Gnomad AMR exome
AF:
0.110
Gnomad ASJ exome
AF:
0.276
Gnomad EAS exome
AF:
0.0199
Gnomad FIN exome
AF:
0.254
Gnomad NFE exome
AF:
0.248
Gnomad OTH exome
AF:
0.215
GnomAD4 exome
AF:
0.222
AC:
324468
AN:
1461748
Hom.:
38108
Cov.:
34
AF XY:
0.222
AC XY:
161310
AN XY:
727184
show subpopulations
African (AFR)
AF:
0.0869
AC:
2908
AN:
33478
American (AMR)
AF:
0.113
AC:
5066
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.273
AC:
7142
AN:
26134
East Asian (EAS)
AF:
0.0291
AC:
1155
AN:
39694
South Asian (SAS)
AF:
0.172
AC:
14802
AN:
86256
European-Finnish (FIN)
AF:
0.253
AC:
13494
AN:
53412
Middle Eastern (MID)
AF:
0.270
AC:
1560
AN:
5768
European-Non Finnish (NFE)
AF:
0.239
AC:
265307
AN:
1111894
Other (OTH)
AF:
0.216
AC:
13034
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
15534
31068
46603
62137
77671
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8778
17556
26334
35112
43890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.186
AC:
28251
AN:
152050
Hom.:
3026
Cov.:
32
AF XY:
0.186
AC XY:
13794
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.0906
AC:
3763
AN:
41514
American (AMR)
AF:
0.174
AC:
2667
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.269
AC:
933
AN:
3468
East Asian (EAS)
AF:
0.0265
AC:
137
AN:
5168
South Asian (SAS)
AF:
0.168
AC:
809
AN:
4822
European-Finnish (FIN)
AF:
0.257
AC:
2708
AN:
10552
Middle Eastern (MID)
AF:
0.289
AC:
85
AN:
294
European-Non Finnish (NFE)
AF:
0.244
AC:
16545
AN:
67928
Other (OTH)
AF:
0.208
AC:
439
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1139
2278
3418
4557
5696
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.230
Hom.:
3157
Bravo
AF:
0.172
ExAC
AF:
0.194
AC:
23607
Asia WGS
AF:
0.0890
AC:
312
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Primary hypomagnesemia Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ala56Pro in exon 1 of CLDN16: This variant is not expected to have clinical si gnificance because it has been identified in 25.09% (16723/66656) of European ch romosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs3214506). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
2.1
DANN
Benign
0.95
DEOGEN2
Benign
0.091
T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.086
N
LIST_S2
Benign
0.50
T;T
MetaRNN
Benign
0.0048
T;T
MetaSVM
Benign
-0.49
T
MutationAssessor
Benign
0.55
N;.
PhyloP100
-0.052
PrimateAI
Benign
0.26
T
PROVEAN
Benign
0.080
N;N
REVEL
Uncertain
0.29
Sift
Benign
0.13
T;T
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.0
B;B
Vest4
0.16
MPC
0.14
ClinPred
0.00072
T
GERP RS
-3.9
PromoterAI
0.063
Neutral
Varity_R
0.070
gMVP
0.12
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3214506; hg19: chr3-190106074; COSMIC: COSV53226998; API